|
WT1 Expression in Patients with Myelodysplastic Syndromes: A Variety of Possibilities in Future Clinical Practice
|
Nov 2016
|
Acta Haematol
|
myelodysplastic syndromes (MDS)
|
|
Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis
|
Apr 2016
|
Acta Haematol
|
myelodysplastic syndromes (MDS)
|
|
Aplastic anemia in adolescents and young adults
|
Sep 2014
|
Acta Haematol
|
aplastic anemia
|
|
Autoimmunity and Inflammation in Myelodysplastic Syndromes
|
Jun 2016
|
Acta Haematol
|
myelodysplastic syndromes (MDS)
|
|
Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview
|
Nov 2014
|
Adv Biol Regul
|
myelodysplastic syndromes (MDS)
|
|
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
|
Sep 2013
|
Adv Biol Regul
|
myelodysplastic syndromes (MDS)
|
|
Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry
|
Aug 2016
|
Adv Clin Exp Med
|
myelodysplastic syndromes (MDS)
|
|
Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies
|
Jan 2013
|
Adv Exp Med Biol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies
|
Jan 2013
|
Adv Exp Med Biol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML
|
Jul 2020
|
Aging
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
